Granules India update on USFDA inspection at Gagillapur facility
Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
Octreotide is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis
Total Income in Q2 FY25 stood at Rs. 532.18 crore
Donation drive in São Paulo aims to support 250 young women’s health and environmental responsibility
This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs
Net Profit was at Rs. 10.04 crore, as compared to Rs. 5.12 crore in Q2 FY24, clocking a growth of 96.22%
The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit
Subscribe To Our Newsletter & Stay Updated